NASDAQConsumer StaplesPackaged FoodsSnapshot 2026-10-15
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
Living Fair Value by QuarterlyIQ
A valuation that evolves as the business changes.
A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.
View Living FV report and workflow4 key conditions need to be met for the investment thesis to play out.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Achieve cost savings of $200 million by Q3 2026 | Profit margins and cost savings support steady cash flow. | Intact | cost savings fall below $200 million by Q3 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Manage leadership transitions without disruption | A supporting condition in Campbell's Company (The)'s published investment case. The stated target is No material disruption from executive departures through early 2027. | Under Pressure | significant disruption or delays from leadership changes | Qualitative: 1 exec departure (Poland) with transition to Jan 2027 Executive Vice President Daniel Poland stepping down, assisting with transition until January 10, 2027. Context reviewed through Oct 15, 2026Last status assessment Oct 15, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain adjusted EBIT near $274 million in Q3 2026 | A supporting condition in Campbell's Company (The)'s published investment case. The stated target is >= $274 million adjusted EBIT. | Broken | adjusted EBIT falls below $274 million in Q3 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextReaffirmed in 3 of last 4 quarters. Full-year fiscal 2026 revenue guidance ranges from $9.7B to $9.98B, Adjusted EBIT from $1.18B to $1.49B, and Adjusted EPS from $2.15 to $2.55. Actual revenue declined from $2.7B in 2026-Q1 to $2.1B in 2026-Q4, with adjusted EBIT and EPS also declining. The trajectory shows management maintaining guidance despite financial headwinds. Delivery assessment Oct 15, 2026 |
Stabilize revenue near $9.8 billion in fiscal 2026 | The company reaffirms full-year revenue near $9.8 billion. | Broken | revenue falls below $9.79 billion in FY 2026 | Revenue: $2.137B FY2026-Q4; GAAP. Published target: >= $9.79 billion total revenue. Target period is not explicitly aligned with this observation. Source published Sep 24, 20262,137,000,000 USD · source valueSource reportLast status assessment Oct 15, 2026Measurement sourceconsolidated · GAAP FY2026-Q4 · Period ending Aug 2, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q4. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 4 of last 4 quarters. Despite revenue declines from $2.7B in 2026-Q1 to $2.1B in 2026-Q4 and adjusted EBIT decline from $383M to $242M, management reiterates confidence in long-term sustainable profitable growth. The trajectory shows persistent focus but financials indicate challenges in near term. Delivery assessment Oct 15, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsLatest: 1 Buy / Strong Buy · 13 Hold · 6 Sell / Strong Sell
Recent actions · Sep 16–Oct 15 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Dec 8, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This investment represents a durable compounder with a focus on sustainable growth. The current thesis state is intact, supported by strong recent financial performance despite challenges in the broader sector.
The market appears to price CPB as cheap compared to its peers, with a low expectations gap. However, the valuation has recently fallen, indicating that some concerns may not be fully reflected in the current price.
Management is on track to achieve significant cost savings, but there are challenges in revenue and profit margins. The near-term risk is moderate, with a low probability of missing earnings expectations, although recent performance has been inconsistent.
The thesis hinges on management's ability to maintain guidance and execute on cost savings. Additionally, external factors such as inflation trends and economic conditions will play a crucial role in shaping future performance.
Over the next 1 to 3 years, CPB's performance will depend on effective management execution and external economic factors. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.